This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, Institut Pasteur Du Cambodge. Active years: 2016-2023.
Company Filing History:
3 out of 897 
2 out of 5,383 
2 out of 5 Years Active: 2016-2023
Title: Odile Puijalon: Innovator in Molecular Markers for Malaria Resistance
Introduction
Odile Puijalon is a prominent inventor based in Issy les Moulineaux, France. She has made significant contributions to the field of molecular biology, particularly in the study of malaria resistance. With a total of 3 patents, her work focuses on developing methods to track and combat artemisinin resistance in Plasmodium falciparum.
Latest Patents
One of her latest patents is centered around the molecular marker of Plasmodium falciparum artemisinin resistance, specifically the K13-propeller polymorphism. This invention is crucial for tracking the emergence and spread of artemisinin-resistant malaria. The patent encompasses various methods, compositions, and kits designed for detecting and genotyping. These innovations can effectively identify the presence or absence of a mutated K-13 propeller nucleic acid or protein in biological samples.
Career Highlights
Throughout her career, Odile has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding of malaria resistance mechanisms, contributing to global health initiatives aimed at combating this deadly disease.
Collaborations
Odile has collaborated with notable colleagues, including Jean-Christophe Barale and Frederic Ariey. These partnerships have further enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Odile Puijalon's innovative work in molecular markers for malaria resistance highlights her dedication to advancing medical science. Her contributions are vital in the ongoing fight against malaria, showcasing the importance of research and innovation in public health.